Indian health authorities have so far approved the use of vaccines developed by AstraZeneca, Bharat Biotech, Russia’s Gamaleya Institute and Moderna.
The government and Moderna are still trying to sort out issues over imports of the vaccine and indemnity, a top executive at Indian drugmaker and Moderna’s local distribution partner Cipla told Reuters in an interview on Friday.
Meanwhile, India’s COVID-19 vaccination coverage has exceeded 48.93 cr. Cumulatively, 48,93,42,295 vaccine doses have been administered through 57,21,937 sessions, as per the provisional report till 7 am today. 37,55,115 vaccine doses were administered in the last 24 hours, said the Union Health Ministry.
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.